Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apixaban”

292 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 292 results

Not applicableStudy completedNCT04435769
What this trial is testing

Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment

Who this might be right for
Atrial Fibrillation
Pfizer 109
Not applicableStudy completedNCT02345343
What this trial is testing

Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Bristol-Myers Squibb 100
Not applicableStudy completedNCT04618913
What this trial is testing

Anticoagulation in Patients With Venous Thromboembolism and Cancer

Who this might be right for
NeoplasmsEmbolism
Pfizer 1
Not applicableEnrolling By InvitationNCT07242326
What this trial is testing

SNAP AF-52: Dose Appropriateness and Adherence to Oral Anticoagulation in Adults ≥65 With Atrial Fibrillation in Primary Care (Ordu, Türkiye)

Who this might be right for
Medication AdherenceAtrial Fibrillation (AF)Direct Oral Anticoagulants (DOACs)
Kotyora Family Medicine Health Management and Education Association 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT05683808
What this trial is testing

Venous Thromboembolism Prevention in Outpatients With Glioma

Who this might be right for
GlioblastomaAstrocytomaVenous Thromboembolism
University of Vermont Medical Center 40
Testing effectiveness (Phase 2)WithdrawnNCT02378623
What this trial is testing

Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli

Who this might be right for
Patent Foramen OvaleCardiac Implantable Electronic Device
Mayo Clinic
Not applicableStudy completedNCT02714855
What this trial is testing

Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France

Who this might be right for
Anticoagulation
Bristol-Myers Squibb 2,081
Early research (Phase 1)Study completedNCT03083782
What this trial is testing

Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus

Who this might be right for
Venous ThromboembolismPharmacokineticsHealthy
Thomas Jefferson University 12
Post-approval studies (Phase 4)UnknownNCT02666157
What this trial is testing

Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
National Cheng-Kung University Hospital 3,672
Not applicableStudy completedNCT04828772
What this trial is testing

Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan

Who this might be right for
COVID-19
Bristol-Myers Squibb 9,282
Not applicableStudy completedNCT05471830
What this trial is testing

An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting

Who this might be right for
Prevention of Thromboembolic EventsAtrial Fibrillation
Bayer 600
Early research (Phase 1)Looking for participantsNCT07024160
What this trial is testing

Phase I Study of MT1011 Injection in Healthy Subjects

Who this might be right for
Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 40
Post-approval studies (Phase 4)Study completedNCT01706146
What this trial is testing

Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring

Who this might be right for
Atrial Fibrillation
Northwestern University 59
Post-approval studies (Phase 4)Study completedNCT05632445
What this trial is testing

Apixaban vs Dual Antiplatet Therapy Study After Left Atrial Appendage Occlosure (ADALA)

Who this might be right for
Left Atrial Appendage Occlusion
DR. XAVIER FREIXA 160
Not applicableStudy completedNCT04435418
What this trial is testing

Eliquis Acute Stroke Safety Evaluation

Who this might be right for
Ischemic StrokeTransient Ischemic AttackAtrial Fibrillation
University of Alberta 100
Not applicableStudy completedNCT03182218
What this trial is testing

Periprocedural Direct Oral Anticoagulant Management

Who this might be right for
Periprocedural Complication
Fundación para la Investigación del Hospital Clínico de Valencia 1,100
Post-approval studies (Phase 4)Looking for participantsNCT06571149
What this trial is testing

Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake

Who this might be right for
Ischemic Stroke
Insel Gruppe AG, University Hospital Bern 906
Not applicableStudy completedNCT05773222
What this trial is testing

Efficacy and Safety of Apixaban in Korean Frail Atrial Fibrillation Patient

Who this might be right for
Atrial Fibrillation
Seoul National University Hospital 2,002
Not applicableNot Yet RecruitingNCT06869083
What this trial is testing

Application-Delivered Patient Education in Enhancing the Usage of Apixaban in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation on Apixaban Treatment
Yonsei University 5,200
Large-scale testing (Phase 3)Study completedNCT03996772
What this trial is testing

PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation

Who this might be right for
Atrial FibrillationIntracerebral Hemorrhage
Imperial College London 319
Next Page